15 results
10-K
2020 FY
AUPH
Aurinia Pharmaceuticals Inc
24 Feb 21
Annual report
4:09pm
with LN to be about 80,000 to 120,000 in the United States.
Similar to other autoimmune disorders, LN is a flaring and remitting disease
6-K
EX-99.2
AUPH
Aurinia Pharmaceuticals Inc
10 Nov 20
Current report (foreign)
4:05pm
combined. Similar to other autoimmune disorders, LN is a flaring and remitting disease. The destructive disease cycle people with LN go through is depicted
6-K
EX-99.2
AUPH
Aurinia Pharmaceuticals Inc
11 Aug 20
Current report (foreign)
4:04pm
150,000 in the United States and 150,000 to 215,000 for Europe and Japan combined. Similar to other autoimmune disorders, LN is a flaring
SUPPL
bxur7r9 66de6ihji7
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
ehv0je 3e5bhtio
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
0o60qesyw1j1rqifn3f
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
wa4pxz l93ah
29 May 20
Registration of securities (Canada)
4:07pm
40-F
EX-99.1
mnxbln0n
5 Mar 20
Annual report (Canada)
4:06pm
SUPPL
3tbpsf
10 Dec 19
Supplemental materials (foreign)
4:31pm
SUPPL
xicjj306uh97 69kn
9 Dec 19
Supplemental materials (foreign)
6:35am
SUPPL
2wo2bhq1dknz00o
13 Sep 19
Supplemental materials (foreign)
5:05pm
40-F
EX-99.1
sgifk3r73
19 Mar 19
Annual report (Canada)
4:16pm
SUPPL
vp7j74lt2glk
30 Nov 18
Supplemental materials (foreign)
5:23pm
- Prev
- 1
- Next